Carl J. Fichtenbaum

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · New England Journal of Medicine · 2021 · 658 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Steven Grinspoon, Kathleen V. Fitch, Markella V. Zanni et al. · New England Journal of Medicine · 2023 · 455 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +10

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047

Carl J. Fichtenbaum, John G. Gerber, Susan L. Rosenkranz et al. · AIDS · 2002 · 339 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy

Francesca J. Torriani, Lauren Komarow, Robert A. Parker et al. · Journal of the American College of Cardiology · 2008 · 299 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15